Synergy Pharmaceuticals, Inc (SGYP) Covered Calls

Synergy Pharmaceuticals, Inc covered calls Synergy Pharmaceuticals, Inc. is a development stage biopharmaceutical company, whose main focus is on the development of drugs to treat GI disorders and diseases.

There are no covered calls available for Synergy Pharmaceuticals, Inc.

Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of drugs to treat gastrointestinal disorders and diseases. Its lead product candidate includes plecanatide a phase 3 guanylate cyclase C, or GC-C, receptor agonist, designed to treat GI disorders, primarily chronic idiopathic constipation, or CIC, and constipation-predominant irritable bowel syndrome, or IBS-C. CIC and IBS-C are functional gastrointestinal disorders that afflict millions of individuals worldwide. The company was founded by Kunwar Shailubhai on November 15, 2005 and is headquartered in New York, NY.